Research & Development



  “我耶耶很貪財,可是,他不會害我們的。”甦稚咬著嘴唇低聲道。   志得意滿的董仲舒為這一場戰爭敲響了結束的鐘鼓。超碰免费视频公开   劉據笑道︰“你只想著做對得起你俸祿的事情嗎?”caoprom超碰地最新地址   志得意滿的董仲舒為這一場戰爭敲響了結束的鐘鼓。   大盾分開,霍光走了出來,低頭看著腳下的努力掙扎的這個滇人,對憤怒的雲氏家將道︰“把他送給捕奴團。”超碰公开   霍去病冷笑道︰“老兵可以不要求,新兵中選拔百夫長,必須識字……”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo